2023
Characterization and diagnosis spectrum of patients with cerebrospinal fluid pleocytosis
Dyckhoff-Shen S, Bewersdorf J, Teske N, Völk S, Pfister H, Koedel U, Klein M. Characterization and diagnosis spectrum of patients with cerebrospinal fluid pleocytosis. Infection 2023, 52: 219-229. PMID: 37656347, PMCID: PMC10811117, DOI: 10.1007/s15010-023-02087-8.Peer-Reviewed Original ResearchConceptsCerebrospinal fluid pleocytosisCerebrospinal fluid cell countBacterial meningitisCerebrospinal fluidCNS infectionCell countElevated white blood cell countResultsThe most common etiologyMethodsA retrospective cohort studyNeoplastic diseaseAutoimmune CNS diseaseWhite blood cell countRetrospective cohort studySpectrum of patientsCharacteristics of patientsBlood cell countCerebrospinal fluid proteinAbnormal mental statusLaboratory featuresCSF pleocytosisCSF leukocytesLaboratory parametersClinical presentationNuchal rigidityCommon etiologies
2021
COVID-19 vaccination and breakthrough infections in patients with cancer
Schmidt A, Labaki C, Hsu C, Bakouny Z, Balanchivadze N, Berg S, Blau S, Daher A, Zarif T, Friese C, Griffiths E, Hawley J, Hayes-Lattin B, Karivedu V, Latif T, Mavromatis B, McKay R, Nagaraj G, Nguyen R, Panagiotou O, Portuguese A, Puc M, Dutra M, Schroeder B, Thakkar A, Wulff-Burchfield E, Mishra S, Farmakiotis D, Shyr Y, Warner J, Choueiri T, Consortium C, Choueiri T, Duma N, Farmakiotis D, Grivas P, de Lima Lopes G, Painter C, Peters S, Rini B, Shah D, Thompson M, Warner J. COVID-19 vaccination and breakthrough infections in patients with cancer. Annals Of Oncology 2021, 33: 340-346. PMID: 34958894, PMCID: PMC8704021, DOI: 10.1016/j.annonc.2021.12.006.Peer-Reviewed Original ResearchConceptsSymptomatic COVID-19COVID-19 vaccineClinical features of patientsRisk of breakthrough infectionClinical efficacy of COVID-19 vaccinesFeatures of patientsSpectrum of patientsHistory of cancerRisk of severe outcomesEfficacy of COVID-19 vaccinesSevere COVID-19Robust antibody titersSystemic therapyActive immunosuppressionHematologic malignanciesBreakthrough infectionClinical efficacyClinical featuresImpaired immunityVaccinated patientsUnvaccinated patientsClinical trialsLethal infectionPatientsAntibody titers
2020
Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial
Chau I, Penel N, Soriano AO, Arkenau HT, Cultrera J, Santana-Davila R, Calvo E, Le Tourneau C, Zender L, Bendell JC, Mi G, Gao L, McNeely SC, Oliveira JM, Ferry D, Herbst RS, Fuchs CS. Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial. Cancers 2020, 12: 2985. PMID: 33076423, PMCID: PMC7602637, DOI: 10.3390/cancers12102985.Peer-Reviewed Original ResearchObjective response rateProgression-free survivalOverall survivalPD-L1GEJ cancerGrade 3 treatment-related adverse eventsTreatment-related adverse eventsAlanine/aspartate aminotransferaseDurable clinical activityFirst-line patientsPrior systemic chemotherapyAntitumor activityDuration of responseSpectrum of patientsStudy design limitationsCheckpoint inhibitorsMetastatic settingPrimary endpointSecondary endpointsSystemic chemotherapyTreatment-naïveAdvanced gastricAdverse eventsAdvanced cancerPositive tumors
2019
A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy
Alsaloum M, Estacion M, Almomani R, Gerrits MM, Bönhof GJ, Ziegler D, Malik R, Ferdousi M, Lauria G, Merkies IS, Faber CG, Dib-Hajj S, Waxman S. A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy. Molecular Pain 2019, 15: 1744806919849802. PMID: 31041876, PMCID: PMC6510061, DOI: 10.1177/1744806919849802.Peer-Reviewed Original ResearchConceptsDiabetic peripheral neuropathyPeripheral neuropathyNeuropathic painDiabetic peripheral neuropathy patientsPainful diabetic peripheral neuropathyDorsal root ganglion neuronsPainful diabetic neuropathyPeripheral neuropathy patientsSodium channel β subunitsSpectrum of patientsUse-dependent inhibitionCardiac conducting systemSodium channel α subunitVoltage-gated sodium channelsChannel α-subunitsSCN11A geneDiabetic neuropathyDiabetes mellitusChronic painNeuropathy patientsGanglion neuronsNegative genetic screeningChannel β subunitHealth sequelaeRepetitive stimulation
2003
Brachytherapy for in-stent restenosis in general interventional practice A single institution's experience using four radiation devices
Singh HS, Roberts KB, Yue N, Nath R, Song GH, Azimi N, Pfau S. Brachytherapy for in-stent restenosis in general interventional practice A single institution's experience using four radiation devices. Cardiovascular Revascularization Medicine 2003, 4: 126-132. PMID: 14984712, DOI: 10.1016/s1522-1865(03)00183-5.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAngioplasty, Balloon, CoronaryBlood Vessel Prosthesis ImplantationBrachytherapyConnecticutCoronary AngiographyCoronary Artery BypassCoronary RestenosisCoronary StenosisEquipment DesignFamily PracticeFemaleFollow-Up StudiesHospital MortalityHumansMaleMiddle AgedRadiation DosageReoperationRetrospective StudiesStentsTreatment OutcomeConceptsMajor adverse cardiac eventsStent restenosisAverage treatment ageEffectiveness of brachytherapyAdverse cardiac eventsSingle institution experienceMinimal lumen diameterRandomized clinical trialsLesion-specific characteristicsSpectrum of patientsMACE rateHospital deathCardiac eventsRenal failureUnstable anginaClinical outcomesCoronary lesionsTreatment failureInstitution experienceFrequent presentationInterventional therapyClinical trialsGeneral populationInterventional practicePatients
1993
Suicide Risk in Patients with Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome
Beckett A, Shenson D. Suicide Risk in Patients with Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome. Harvard Review Of Psychiatry 1993, 1: 27-35. PMID: 9384825, DOI: 10.3109/10673229309017054.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionSuicide riskImmunodeficiency syndromeVirus infectionSuicidal ideationHIV/AIDS populationAcquired Immunodeficiency SyndromeSpectrum of patientsDisease-specific stressorsOwn clinical experienceSuicide risk factorsHIV infectionAIDS populationRisk factorsGeneral populationClinical experiencePatientsInfectionSyndromeHigh rateSuicideRiskIdeationCareful exploration
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply